Eliasson E - Search Results

1

Validation of methods for CYP2C9 genotyping: frequencies of mutant alleles in a Swedish population.

Yasar U, Eliasson E, Dahl ML, Johansson I, Ingelman-Sundberg M, Sjöqvist F. Yasar U, et al. Among authors: eliasson e. Biochem Biophys Res Commun. 1999 Jan 27;254(3):628-31. doi: 10.1006/bbrc.1998.9992. Biochem Biophys Res Commun. 1999. PMID: 9920790

2

Pharmacokinetics of losartan and its metabolite E-3174 in relation to the CYP2C9 genotype.

Yasar U, Forslund-Bergengren C, Tybring G, Dorado P, Llerena A, Sjöqvist F, Eliasson E, Dahl ML. Yasar U, et al. Among authors: eliasson e. Clin Pharmacol Ther. 2002 Jan;71(1):89-98. doi: 10.1067/mcp.2002.121216. Clin Pharmacol Ther. 2002. PMID: 11823761 Clinical Trial.

3

Linkage between the CYP2C8 and CYP2C9 genetic polymorphisms.

Yasar U, Lundgren S, Eliasson E, Bennet A, Wiman B, de Faire U, Rane A. Yasar U, et al. Among authors: eliasson e. Biochem Biophys Res Commun. 2002 Nov 22;299(1):25-8. doi: 10.1016/s0006-291x(02)02592-5. Biochem Biophys Res Commun. 2002. PMID: 12435384

4

Hormone controlled phosphorylation and degradation of CYP2B1 and CYP2E1 in isolated rat hepatocytes.

Johansson I, Eliasson E, Ingelman-Sundberg M. Johansson I, et al. Among authors: eliasson e. Biochem Biophys Res Commun. 1991 Jan 15;174(1):37-42. doi: 10.1016/0006-291x(91)90481-l. Biochem Biophys Res Commun. 1991. PMID: 1989615

5

Ligand-dependent maintenance of ethanol-inducible cytochrome P-450 in primary rat hepatocyte cell cultures.

Eliasson E, Johansson I, Ingelman-Sundberg M. Eliasson E, et al. Biochem Biophys Res Commun. 1988 Jan 15;150(1):436-43. doi: 10.1016/0006-291x(88)90539-6. Biochem Biophys Res Commun. 1988. PMID: 3337723

6

Role of CYP2C9 polymorphism in losartan oxidation.

Yasar U, Tybring G, Hidestrand M, Oscarson M, Ingelman-Sundberg M, Dahl ML, Eliasson E. Yasar U, et al. Among authors: eliasson e. Drug Metab Dispos. 2001 Jul;29(7):1051-6. Drug Metab Dispos. 2001. PMID: 11408373

7

The role of CYP2C9 genotype in the metabolism of diclofenac in vivo and in vitro.

Yasar U, Eliasson E, Forslund-Bergengren C, Tybring G, Gadd M, Sjöqvist F, Dahl ML. Yasar U, et al. Among authors: eliasson e. Eur J Clin Pharmacol. 2001 Dec;57(10):729-35. doi: 10.1007/s00228-001-0376-7. Eur J Clin Pharmacol. 2001. PMID: 11829203

8

Association of CYP2C9 genotypes leading to high enzyme activity and colorectal cancer risk.

Yasar U, Eliasson E, Dahl ML. Yasar U, et al. Among authors: eliasson e. Carcinogenesis. 2002 Apr;23(4):665; author reply 667-8. doi: 10.1093/carcin/23.4.665. Carcinogenesis. 2002. PMID: 11960920 No abstract available.

9

Oxidation of celecoxib by polymorphic cytochrome P450 2C9 and alcohol dehydrogenase.

Sandberg M, Yasar U, Strömberg P, Höög JO, Eliasson E. Sandberg M, et al. Among authors: eliasson e. Br J Clin Pharmacol. 2002 Oct;54(4):423-9. doi: 10.1046/j.1365-2125.2002.01660.x. Br J Clin Pharmacol. 2002. PMID: 12392591 Free PMC article.

10

Bioactivation of cyclophosphamide: the role of polymorphic CYP2C enzymes.

Griskevicius L, Yasar U, Sandberg M, Hidestrand M, Eliasson E, Tybring G, Hassan M, Dahl ML. Griskevicius L, et al. Among authors: eliasson e. Eur J Clin Pharmacol. 2003 Jun;59(2):103-9. doi: 10.1007/s00228-003-0590-6. Epub 2003 Apr 9. Eur J Clin Pharmacol. 2003. PMID: 12684728

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

144 results

Search Page

Filters